GILT expression in B cells diminishes cathepsin S steady-state protein expression and activity

European Journal of Immunology

Volumn 43, Issue 1, 2013, Pages 65-74

  Phipps Yonas, Hannah ^a,b   Semik, Vikki ^a   Hastings, Karen Taraszka ^a,b,c  

^a UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

Antigen presentation processing; Antigen presenting cells; B cells; Cathepsin S; Gamma interferon inducible lysosomal thiol reductase (GILT)

Indexed keywords

CATHEPSIN B; CATHEPSIN L; CATHEPSIN S; GAMMA INTERFERON INDUCIBLE LYSOSOMAL THIOL REDUCTASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; OXIDOREDUCTASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; B LYMPHOCYTE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DISULFIDE BOND; ENZYME ACTIVE SITE; HUMAN; HUMAN CELL; LYSOSOME; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY;

ANIMALS; ANTIGEN PRESENTATION; B-LYMPHOCYTES; CATALYTIC DOMAIN; CATHEPSINS; CELL LINE; HUMANS; LYSOSOMES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROSCOPY, CONFOCAL; MUTATION; OXIDATION-REDUCTION; OXIDOREDUCTASES; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN STABILITY;

EID: 84872498812     PISSN: 00142980     EISSN: 15214141     Source Type: Journal    
DOI: 10.1002/eji.201242379     Document Type: Article

References (48)

1. Rocha, N. and Neefjes, J., MHC class II molecules on the move for successful antigen presentation. EMBO J 2008. 27: 1-5.
2. Anderson, M. S. and Miller, J., Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. Proc. Natl. Acad. Sci. USA 1992. 89: 2282-2286.
3. Bakke, O. and Dobberstein, B., MHC class II-associated invariant chain contains a sorting signal for endosomal compartments. Cell 1990. 63: 707-716.
4. Ghosh, P., Amaya, M., Mellins, E. and Wiley, D. C., The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 1995. 378: 457-462.
5. Lotteau, V., Teyton, L., Peleraux, A., Nilsson, T., Karlsson, L., Schmid, S. L., Quaranta, V. et al., Intracellular transport of class II MHC molecules directed by invariant chain. Nature 1990. 348: 600-605.
6. Morkowski, S., Goldrath, A. W., Eastman, S., Ramachandra, L., Freed, D. C., Whiteley, P. and Rudensky, A., T cell recognition of major histocompatibility complex class II complexes with invariant chain processing intermediates. J. Exp. Med. 1995. 182: 1403-1413.
7. Romagnoli, P. and Germain, R. N., The CLIP region of invariant chain plays a critical role in regulating major histocompatibility complex class II folding, transport, and peptide occupancy. J. Exp. Med. 1994. 180: 1107-1113.
8. Tulp, A., Verwoerd, D., Dobberstein, B., Ploegh, H. L. and Pieters, J., Isolation and characterization of the intracellular MHC class II compartment. Nature 1994. 369: 120-126.
9. West, M. A., Lucocq, J. M. and Watts, C., Antigen processing and class II MHC peptide-loading compartments in human B-lymphoblastoid cells. Nature 1994. 369: 147-151.
10. Maric, M. A., Taylor, M. D. and Blum, J. S., Endosomal aspartic proteinases are required for invariant-chain processing. Proc. Natl. Acad. Sci. USA 1994. 91: 2171-2175.
11. Neefjes, J. J. and Ploegh, H. L., Inhibition of endosomal proteolytic activity by leupeptin blocks surface expression of MHC class II molecules and their conversion to SDS resistance alpha beta heterodimers in endosomes. EMBO J. 1992. 11: 411-416.
12. Riese, R. J., Wolf, P. R., Bromme, D., Natkin, L. R., Villadangos, J. A., Ploegh, H. L. and Chapman, H. A., Essential role for cathepsin S in MHC class II-associated invariant chain processing and peptide loading. Immunity 1996. 4: 357-366.
13. Nakagawa, T. Y., Brissette, W. H., Lira, P. D., Griffiths, R. J., Petrushova, N., Stock, J., McNeish, J. D. et al., Impaired invariant chain degradation and antigen presentation and diminished collagen-induced arthritis in cathepsin S null mice. Immunity 1999. 10: 207-217.
14. Shi, G. P., Villadangos, J. A., Dranoff, G., Small, C., Gu, L., Haley, K. J., Riese, R. et al., Cathepsin S required for normal MHC class II peptide loading and germinal center development. Immunity 1999. 10: 197-206.
15. Riese, R. J., Mitchell, R. N., Villadangos, J. A., Shi, G. P., Palmer, J. T., Karp, E. R., De Sanctis, G. T. et al., Cathepsin S activity regulates antigen presentation and immunity. J. Clin. Invest. 1998. 101: 2351-2363.
16. Hastings, K. T., Lackman, R. L. and Cresswell, P., Functional requirements for the lysosomal thiol reductase GILT in MHC class II-restricted antigen processing. J. Immunol. 2006. 177: 8569-8577.
17. Maric, M., Arunachalam, B., Phan, U. T., Dong, C., Garrett, W. S., Cannon, K. S., Alfonso, C. et al., Defective antigen processing in GILT-free mice. Science 2001. 294: 1361-1365.
18. Rausch, M. P., Irvine, K. R., Antony, P. A., Restifo, N. P., Cresswell, P. and Hastings, K. T., GILT accelerates autoimmunity to the melanoma antigen tyrosinase-related protein 1. J. Immunol. 2010. 185: 2828-2835.
19. Denzin, L. K. and Cresswell, P., HLA-DM induces CLIP dissociation from MHC class II alpha beta dimers and facilitates peptide loading. Cell 1995. 82: 155-165.
20. Denzin, L. K., Hammond, C. and Cresswell, P., HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J. Exp. Med. 1996. 184: 2153-2165.
21. Denzin, L. K., Sant'Angelo, D. B., Hammond, C., Surman, M. J. and Cresswell, P., Negative regulation by HLA-DO of MHC class II-restricted antigen processing. Science 1997. 278: 106-109.
22. Fallas, J. L., Tobin, H. M., Lou, O., Guo, D., Sant'Angelo, D. B. and Denzin, L. K., Ectopic expression of HLA-DO in mouse dendritic cells diminishes MHC class II antigen presentation. J. Immunol. 2004. 173: 1549-1560.
23. Arunachalam, B., Phan, U. T., Geuze, H. J. and Cresswell, P., Enzymatic reduction of disulfide bonds in lysosomes: characterization of a gamma-interferon-inducible lysosomal thiol reductase (GILT). Proc. Natl. Acad. Sci. USA 2000. 97: 745-750.
24. Haque, M. A., Li, P., Jackson, S. K., Zarour, H. M., Hawes, J. W., Phan, U. T., Maric, M. et al., Absence of γ-interferon-inducible lysosomal thiol reductase in melanomas disrupts T cell recognition of select immunodominant epitopes. J. Exp. Med. 2002. 195: 1267-1277.
25. Honey, K., Duff, M., Beers, C., Brissette, W. H., Elliott, E. A., Peters, C., Maric, M. et al., Cathepsin S regulates the expression of cathepsin L and the turnover of γ-interferon-inducible lysosomal thiol reductase in B lymphocytes. J. Biol. Chem. 2001. 276: 22573-22578.
26. Phan, U. T., Arunachalam, B. and Cresswell, P., Gamma-interferon-inducible lysosomal thiol reductase (GILT). Maturation, activity, and mechanism of action. J. Biol. Chem. 2000. 275: 25907-25914.
27. Arunachalam, B., Pan, M. and Cresswell, P., Intracellular formation and cell surface expression of a complex of an intact lysosomal protein and MHC class II molecules. J. Immunol. 1998. 160: 5797-5806.
28. Singh, R. and Cresswell, P., Defective cross-presentation of viral antigens in GILT-free mice. Science 2010. 328: 1394-1398.
29. Rausch, M. P. and Hastings, K. T., GILT modulates CD4(+) T-cell tolerance to the melanocyte differentiation antigen tyrosinase-related protein 1. J. Invest. Dermatol. 2012. 132: 154-162.
30. Goldstein, O. G., Hajiaghamohseni, L. M., Amria, S., Sundaram, K., Reddy, S. V. and Haque, A., Gamma-IFN-inducible-lysosomal thiol reductase modulates acidic proteases and HLA class II antigen processing in melanoma. Cancer Immunol. Immunother. 2008. 57: 1461-1470.
31. Deussing, J., Roth, W., Saftig, P., Peters, C., Ploegh, H. L. and Villadangos, J. A., Cathepsins B and D are dispensable for major histocompatibility complex class II-mediated antigen presentation. Proc. Natl. Acad. Sci. USA 1998. 95: 4516-4521.
32. Villadangos, J. A., Riese, R. J., Peters, C., Chapman, H. A. and Ploegh, H. L., Degradation of mouse invariant chain: roles of cathepsins S and D and the influence of major histocompatibility complex polymorphism. J. Exp. Med. 1997. 186: 549-560.
33. Blander, J. M. and Medzhitov, R., Toll-dependent selection of microbial antigens for presentation by dendritic cells. Nature 2006. 440: 808-812.
34. Nakagawa, T., Roth, W., Wong, P., Nelson, A., Farr, A., Deussing, J., Villadangos, J. A. et al., Cathepsin L: critical role in Ii degradation and CD4 T cell selection in the thymus. Science 1998. 280: 450-453.
35. Portnoy, D. A., Erickson, A. H., Kochan, J., Ravetch, J. V. and Unkeless, J. C., Cloning and characterization of a mouse cysteine proteinase. J. Biol. Chem. 1986. 261: 14697-14703.
36. Turkenburg, J. P., Lamers, M. B., Brzozowski, A. M., Wright, L. M., Hubbard, R. E., Sturt, S. L. and Williams, D. H., Structure of a Cys25->Ser mutant of human cathepsin S. Acta Crystallogr. D Biol. Crystallogr. 2002. 58: 451-455.
37. Lennon-Dumenil, A. M., Bakker, A. H., Maehr, R., Fiebiger, E., Overkleeft, H. S., Rosemblatt, M., Ploegh, H. L. et al., Analysis of protease activity in live antigen-presenting cells shows regulation of the phagosomal proteolytic contents during dendritic cell activation. J. Exp. Med. 2002. 196: 529-540.
38. Sealy, R., Chaka, W., Surman, S., Brown, S. A., Cresswell, P. and Hurwitz, J. L., Target peptide sequence within infectious human immunodeficiency virus type 1 does not ensure envelope-specific T-helper cell reactivation: influences of cysteine protease and gamma interferon-induced thiol reductase activities. Clin. Vaccine Immunol. 2008. 15: 713-719.
39. Vidard, L., Rock, K. L. and Benacerraf, B., The generation of immunogenic peptides can be selectively increased or decreased by proteolytic enzyme inhibitors. J. Immunol. 1991. 147: 1786-1791.
40. Trombetta, E. S., Ebersold, M., Garrett, W., Pypaert, M. and Mellman, I., Activation of lysosomal function during dendritic cell maturation. Science 2003. 299: 1400-1403.
41. Bogunovic, B., Srinivasan, P., Ueda, Y., Tomita, Y. and Maric, M., Comparative quantitative mass spectrometry analysis of MHC class II-associated peptides reveals a role of GILT in formation of self-peptide repertoire. PLoS One 2010. 5: e10599.
42. Saegusa, K., Ishimaru, N., Yanagi, K., Arakaki, R., Ogawa, K., Saito, I., Katunuma, N. et al., Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity. J. Clin. Invest. 2002. 110: 361-369.
43. Baugh, M., Black, D., Westwood, P., Kinghorn, E., McGregor, K., Bruin, J., Hamilton, W. et al., Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity. J. Autoimmun. 2011. 36: 201-209.
44. Pierre, P. and Mellman, I., Developmental regulation of invariant chain proteolysis controls MHC class II trafficking in mouse dendritic cells. Cell 1998. 93: 1135-1145.
45. El-Sukkari, D., Wilson, N. S., Hakansson, K., Steptoe, R. J., Grubb, A., Shortman, K. and Villadangos, J. A., The protease inhibitor cystatin C is differentially expressed among dendritic cell populations, but does not control antigen presentation. J. Immunol. 2003. 171: 5003-5011.
46. Bolte, S. and Cordelieres, F. P., A guided tour into subcellular colocalization analysis in light microscopy. J. Microsc. 2006. 224: 213-232.
47. Manders, E. M., Stap, J., Brakenhoff, G. J., van Driel, R. and Aten, J. A., Dynamics of three-dimensional replication patterns during the S-phase, analysed by double labelling of DNA and confocal microscopy. J. Cell Sci. 1992. 103(Pt 3): 857-862.
48. Fallas, J. L., Yi, W., Draghi, N. A., O'Rourke, H. M. and Denzin, L. K., Expression patterns of H2-O in mouse B cells and dendritic cells correlate with cell function. J. Immunol. 2007. 178: 1488-1497.